Drug combo curbs viral load in difficult-to-treat HCV patients

08/27/2013 | DoctorsLounge.com · MedPage Today (free registration)

Sofosbuvir plus rivabirin showed efficacy in reducing viral load in patients infected with hepatitis C who are considered unlikely to respond to treatment, data show. No deaths were recorded, and no patients stopped treatment due to adverse events. The findings appear in the Journal of the American Medical Association.

View Full Article in:

DoctorsLounge.com · MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ